Related Experiment Video
Updated: Jul 13, 2026

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring
Published on: November 17, 2018
Statins and metabolism of high density lipoprotein
Dmitri Sviridov1, Paul Nestel, Gerald Watts
1Baker Heart Research Institute, Commercial Rd., Central, Melbourne, Vic., 8008, Australia. Dmitri.Sviridov@Baker.edu.au
Insights
Statins effectively lower cholesterol and cardiovascular risk by reducing LDL. Their impact on high-density lipoprotein (HDL) metabolism and reverse cholesterol transport is complex and not fully understood.
Area of Science:
- Biochemistry
- Cardiology
- Pharmacology
Background:
- Statins inhibit HMG-CoA reductase, the key enzyme in cholesterol biosynthesis.
- They are widely used to lower plasma cholesterol, reducing cardiovascular disease risk.
- Statins lower low-density lipoprotein (LDL) by enhancing hepatic clearance.
Purpose of the Study:
- To review the current understanding of statin effects on high-density lipoprotein (HDL) metabolism.
- To explore the mechanisms behind statin-induced HDL elevation.
- To analyze the role of HDL in statin's atheroprotective effects.
Main Methods:
- Literature review of studies on statins and HDL metabolism.
- Analysis of proposed mechanisms for statin-HDL interactions.
- Evaluation of the contribution of HDL changes to statin efficacy.
Main Results:
- Statins are known to mildly increase HDL concentration.
- Potential mechanisms include inhibition of cholesteryl ester transfer protein (CETP) and stimulation of apolipoprotein A-I synthesis.
- Upregulation of the ABCA1 transporter in the liver may also contribute to increased HDL.
Conclusions:
- The precise mechanisms by which statins influence HDL metabolism require further elucidation.
- While increased HDL-C may contribute to atheroprotection, its magnitude is uncertain.
- Improvements in HDL functionality may be as crucial as HDL-C level changes for cardiovascular benefits.
Abstract:
Statins are competitive inhibitors of HMG-CoA reductase, the rate-limiting enzyme of cholesterol biosynthesis. Statins are widely and successfully used for lowering plasma cholesterol levels causing up to 45% reduction of plasma cholesterol and considerable reduction in risk of cardiovascular diseases. The main atheroprotective action of statins is reduction of plasma low density lipoprotein levels due to improved clearance of this lipoprotein by the liver. In addition, statins cause mild elevation of high density lipoprotein (HDL) concentration, but the mechanism responsible for this effect of statins on HDL metabolism is not well understood. It has been hypothesized that statins affect the HDL level through inhibition of cholesteryl ester transfer protein activity or by stimulating apolipoprotein A-I synthesis. Increased cholesterol efflux from liver due to raised expression of the ABCA1 transporter may also elevate HDL levels. Whereas raising the plasma HDL-C concentration may contribute to the atheroprotective effect of statins, its magnitude is uncertain and additional mechanisms that improve the functionality of HDL may be equally or more important. In this review we analyze what is currently known about effect of statins on HDL metabolism and on reverse cholesterol transport in particular.
Related Concept Videos
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Cholesterol: Significance and Regulation
Considering cholesterol and...
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Atherosclerosis III: Management
Lipids: Dietary Sources and Requirements